Quarterly results · MAHALIFE

MAHAMAYA LIFESCIENCES LIMITED Quarterly Results (MAHALIFE) — Q1 FY26

MAHAMAYA LIFESCIENCES LIMITED reported revenue of ₹83.01 cr and net profit of ₹4.1 cr in Q1 FY26 (quarter ended 30 Jun 2025). Below is the full quarter-wise results table with revenue, operating profit, margins, tax, EPS and annual history — updated automatically from exchange filings.

Next results date

Awaiting intimation

MAHALIFE Q1 FY26 results at a glance

MAHAMAYA LIFESCIENCES LIMITED Q1 FY26 key results metrics
QuarterQ1 FY26
Quarter ended30 Jun 2025
Revenue₹83.01 cr
Revenue YoY
Operating profit₹6.82 cr
Operating margin8.2%
Net profit₹4.1 cr
Net profit YoY
Net profit QoQ
Net margin4.9%
Basic EPS₹1.75
TTM revenue
TTM net profit
TTM net margin

MAHALIFE Q1 FY26 results: what the numbers say

MAHAMAYA LIFESCIENCES LIMITED (MAHALIFE) has reported its Q1 FY26 results for the quarter ended 2025-06-30. The company posted revenue of ₹83.01 cr and a net profit of ₹4.1 cr, translating into earnings per share of ₹1.75.

Operating profit for the quarter stood at ₹6.82 cr, an operating margin of 8.2%.

MAHALIFE quarter-wise results table

Revenue

₹83.01 cr

YoY

Net profit

₹4.1 cr

YoY

Operating profit

₹6.82 cr

YoY

EPS

₹1.75

YoY

MAHAMAYA LIFESCIENCES LIMITED (MAHALIFE) quarter-wise results — revenue, operating profit, net profit, margins, EPS and growth
QuarterRevenueOperating profitNet profitOPMNet marginEPSProfit YoYProfit QoQ
Q1 FY262025-06-30₹83.01 cr₹6.82 cr₹4.1 cr8.2%4.9%₹1.75

Consolidated figures as reported to the exchanges, shown in ₹ crore. OPM = operating profit margin. Updated automatically whenever a new quarter is filed.

MAHALIFE quarterly income statement

Line-item results for the last six quarters as filed — sales, expenses, operating profit, interest, tax and profit after tax in ₹ crore.

MAHAMAYA LIFESCIENCES LIMITED quarterly income statement
ParticularsQ1 FY262025-06-30
Revenue / Sales₹83.01 cr
Total expenses₹76.19 cr
Gross profit₹11.18 cr
Operating profit (EBIT)₹6.82 cr
Operating margin8.2%
Interest cost₹1.8 cr
Profit before tax₹5.69 cr
Tax expense₹1.59 cr
Effective tax rate27.9%
Net profit (PAT)₹4.1 cr
Net profit margin4.9%
Basic EPS₹1.75
Diluted EPS₹1.75

MAHALIFE annual results history

Full-year performance for MAHAMAYA LIFESCIENCES LIMITED, useful for reading each quarter in context.

MAHAMAYA LIFESCIENCES LIMITED annual income statement
ParticularsFY262026-03-31FY252025-03-31FY242024-03-31FY232023-03-31
Revenue / Sales₹329 cr₹264 cr₹162 cr₹137 cr
Total expenses₹293 cr₹241 cr₹150 cr₹129 cr
Gross profit₹54.03 cr₹37.35 cr₹22.39 cr₹18.62 cr
Operating profit (EBIT)₹35.5 cr₹22.91 cr₹11.78 cr₹8.27 cr
Operating margin10.8%8.7%7.3%6.0%
Interest cost₹7.4 cr₹5.49 cr₹4.76 cr₹2.55 cr
Profit before tax₹23.88 cr₹17.25 cr₹7.12 cr₹5.1 cr
Tax expense₹7.35 cr₹4.44 cr₹1.9 cr₹1.35 cr
Effective tax rate30.8%25.7%26.7%26.4%
Net profit (PAT)₹16.52 cr₹12.81 cr₹5.22 cr₹3.75 cr
Net profit margin5.0%4.9%3.2%2.7%
Basic EPS₹5.47₹2.23₹1.60
Diluted EPS₹5.47₹2.23₹1.60

Revenue trend and demand read-through

Topline for Q1 FY26 came in at ₹83.01 cr.

Total expenses for the quarter were ₹76.19 cr, or 91.8% of revenue.

Margins, tax and profitability

Net profit of ₹4.1 cr works out to a net margin of 4.9%.

Below the operating line, MAHAMAYA LIFESCIENCES LIMITED reported profit before tax of ₹5.69 cr, a tax charge of ₹1.59 cr (effective rate 27.9%), interest cost of ₹1.8 cr. Reading these together with operating profit shows how much of the quarter's earnings were driven by the core business versus financing and tax movements.

Trailing twelve months and annual context

On a full-year basis, FY26 revenue was ₹329 cr with net profit of ₹16.52 cr and EPS of —, versus the prior year where revenue grew +24.5% and profit grew +29.0%.

What to watch in the next MAHALIFE quarter

For the coming quarters the numbers worth tracking on this page are revenue momentum, the operating margin trend, the interest burden and whether EPS keeps pace with profit growth. A single weak quarter matters less than the direction over three to four consecutive quarters.

MAHAMAYA LIFESCIENCES LIMITED has not yet intimated its next results date to the exchange. This page refreshes automatically from filings and the board-meeting calendar, so the tables above will reflect the next quarter as soon as it is reported.

All figures here are as reported to the exchanges and shown in ₹ crore, without adjustment. This is information and analysis, not investment advice.

MAHALIFE results coverage

No results report published for MAHALIFE yet — our desk covers each quarter within minutes of the filing.

MAHALIFE quarterly results FAQs

What were MAHAMAYA LIFESCIENCES LIMITED (MAHALIFE) Q1 FY26 results?

In Q1 FY26 (quarter ended 30 Jun 2025), MAHAMAYA LIFESCIENCES LIMITED reported revenue of ₹83.01 cr and net profit of ₹4.1 cr. EPS stood at ₹1.75.

What is MAHALIFE profit margin in Q1 FY26?

MAHAMAYA LIFESCIENCES LIMITED posted a net profit margin of 4.9% and an operating margin of 8.2% in Q1 FY26. On a trailing twelve-month basis, revenue is — and net profit —.

Did MAHALIFE results beat the previous quarter?

Sequential comparison for MAHALIFE will appear once two consecutive quarters are filed.

When are MAHAMAYA LIFESCIENCES LIMITED (MAHALIFE) quarterly results?

MAHAMAYA LIFESCIENCES LIMITED has not yet intimated its next results date to the exchange. This page updates automatically from the exchange board-meeting calendar.

Where can I see MAHALIFE latest quarterly results?

Results coverage for MAHALIFE will appear here as soon as the company reports. Meanwhile you can track live price and technicals on the MAHALIFE stock page.

What is MAHAMAYA LIFESCIENCES LIMITED annual revenue and profit?

For FY26, MAHAMAYA LIFESCIENCES LIMITED reported full-year revenue of ₹329 cr and net profit of ₹16.52 cr, with EPS of —.

How many quarterly results has MAHALIFE declared recently?

Past results dates for MAHALIFE will be listed here from the exchange calendar.

Results dates sourced from the exchange board-meeting calendar; reported figures from company filings, last refreshed 12 Sept 2026. For information only, not investment advice.